FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients

Phippen, Neil

468
FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

N. T. Phippen¹, G. Wang², N. W. Bateman², W. J. Lowery³, M. P. Stany³, C. A. Hamilton³, G. L. Maxwell⁴, T. P. Conrads² and K. M. Darcy²
¹Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, ²Gynecologic Cancer Center of Excellence, Annandale, VA, ³Walter Reed National Military Medical Center, Bethesda, MD, ⁴Inova Fairfax Hospital, Falls Church, VA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

468
FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients

468 FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients

468
FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients